Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.


We would like to congratulate Dr Niall Gallen, CTO at Glyconics, which is part of the Deepbridge Life Sciences EIS portfolio, for making the #21toWatch people shortlist. 

This list highlights the creative individuals in the business community who have thrived to evolve the technology industry. Dr Gallen has over 20 years’ experience in the medtech industry, designing and developing electo-optical systems from initial concept to transfer of design. 

To see the full list, click please here. 


To find out more about Glyconics, please click here